Mental HealthChild WellbeingInfant HealthChild HealthReproductive HealthHealthy AgingHealth EquityQuality of LifeSocial Determinants of HealthEnvironmental ExposureGeneticsCognitionLearningChild DevelopmentCongenital AbnormalitiesDisabilityInjuriesCommunicable DiseasesNoncommunicable DiseasesPhysical FitnessDietObesityAllergy and ImmunologyInflammationIntergenerational Relations
Study summary
Generation Victoria (GenV) is a longitudinal, population-based study of Victorian children and their parents that will bring together data on a wide range of conditions ,exposures and outcomes. GenV blends study-collected, study-enhanced and linked data. It will be multi-purpose, supporting observational, interventional, health services and policy research within the same cohort. It is designed to address physical, mental and social issues experienced during childhood, as well as the antecedents of a wide range of diseases of ageing. It seeks to generate translatable evidence (prediction, prevention, treatments, services) to improve future wellbeing and reduce the future disease burden of children and adults.
The GenV Cohort 2020s is open to all children born over a two-year period, and their parents, residing in the state of Victoria Australia. The GenV Cohort 2020s is preceded by an Advance Cohort of children born between 5 Dec 2020 and 3 October 2021, and their parents. This comprises all families recruited at GenV's Vanguard hospital (Joan Kirner Women's and Children's) and at birthing hospitals throughout Victoria as GenV scaled up to commence recruiting for the GenV Cohort 2020s. The Advance Cohort have ongoing and full participation in GenV for their lifetime unless they withdraw but may have less complete data and biosamples.
Eligibility
Sex
ALL
Min age
1 Day
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria (Children):
* Birth date between 4th October 2021 and 3rd October 2023
* Live at the time of recruitment
* Residing in Victoria at the time of recruitment
* Has a legally acceptable representative capable of understanding the informed consent document and providing consent on the child's behalf, who provides a signed and dated informed consent form (e.g. a parent/guardian)
Inclusion Criteria (Adults):
* Be a parent or guardian of a child who meets the eligibility criteria above
* Provide a signed and dated informed consent form or have a legally acceptable representative capable of understanding the informed consent document and providing consent on the participant's behalf.
Exclusion criteria:
* Children who are deceased at the time of recruitment (i.e. still born or died after birth) and their parents/guardians
* Families unable to provide informed consent in any of the languages available
Primary outcome measure(s)
Number of parents and children enrolled in the GenV Cohort 2020s — Point of consent until study completion (up to 10 years) Assessed by analysis of records in the study-specific Participant Relationship Management System (PRMS)
Number of participants with complete data collection at each wave — Point of consent until study completion (up to 10 years) Assessed by analysis of records in the study-specific Participant Relationship Management System (PRMS), e-Consent platform and GenV data repository
Number of participants with successful data linkage at each wave — Point of consent until study completion (up to 10 years) Assessed by analysis of records in the study-specific Participant Relationship Management System (PRMS), e-Consent platform and GenV data repository
Number of participants with the targeted biosamples received at each wave — Point of consent until study completion (up to 10 years) Assessed by analysis of records in the study-specific Participant Relationship Management System (PRMS), e-Consent platform and GenV Laboratory Information Management System (LIMS)
Trial sites (1)
Facility
City
Region
Status
Murdoch Children's Research Institute
Parkville
Victoria
Recruiting
More Murdoch Childrens Research Institute trials in Australia
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
